Who owns Spectrum Pharmaceuticals?

Key details on Spectrum Pharmaceuticals (Ticker: SPPI)

Who owns Spectrum Pharmaceuticals?

Is SPPI a good stock to own? Find out who bought Spectrum Pharmaceuticals, who sold Spectrum Pharmaceuticals (SPPI) stock, and who holds a large position in Spectrum Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
BlackRock Fund Advisors 5.94M $35.81M Dec. 31, 2015
Vanguard 5.12M $30.90M Dec. 31, 2015
ARMISTICE CAPITAL 4.44M $30.34M June 30, 2015
FMR 4.24M $25.58M Dec. 31, 2015
Baker Bros. Advisors 3.32M $38.85M Sept. 30, 2012
STATE STREET CORPORATION 2.76M $16.67M Dec. 31, 2015
Renaissance Technologies 2.59M $15.63M Dec. 31, 2015
Broadfin Capital 2.52M $15.05M Sept. 30, 2015
Wellington Management Company 2.43M $16.65M June 30, 2015
Millennium Management 2.28M $13.84M March 31, 2015
Acadian Asset Management 2.09M $13.26M March 31, 2016
BlackRock Institutional Trust Company, N.A. 1.80M $10.84M Dec. 31, 2015
Scopia Management 1.71M $26.67M June 30, 2012
Barclays 1.61M $20.27M March 31, 2012
Tang Capital Management 1.55M $18.15M Sept. 30, 2012
BANK OF MONTREAL /CAN/ 1.52M $12.34M Sept. 30, 2014
GOLDMAN SACHS 1.37M $8.24M Dec. 31, 2015
Deutsche Bank Aktiengesellschaft 1.33M $8.03M Dec. 31, 2015
D. E. Shaw & Co 1.33M $11.14M Sept. 30, 2013
venBio Select Advisor 1.32M $7.87M Sept. 30, 2015
F^C Asset Management 1.30M $10.24M March 31, 2014
Deerfield Management Company 1.27M $9.92M March 31, 2014
Ashford Capital Management 1.25M $8.55M June 30, 2015
DIMENSIONAL FUND ADVISORS 1.20M $7.25M Dec. 31, 2015